[1] 唐志斌. 缬沙坦联合硝苯地平对原发性高血压患者血压和凝血功能的影响[J].现代医学与健康研究电子杂志,2021,5(20):133-136.
[2] Yang Y, Li Z, Guo X, et al.Interventricular Septum Thickness for the Prediction of Coronary Heart Disease and Myocardial Infarction in Hypertension Population: A Prospective Study[J].Journal of Clinical Medicine,2022,11(23):7152-7152.
[3] Kozhevnikova MV, Krivova AV, Korobkova EO, et al.Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease[J].Kardiologiia,2022,62(11):40-48.
[4] 吴德彬. 缬沙坦联合硝苯地平对原发性高血压合并冠心病患者血压及心功能的影响[J].临床合理用药杂志,2021,14(28):12-14.
[5] 陆再英,钟南山.内科学[M].8版.北京:人民卫生出版社,2013:162-177.
[6] Liu Y, Ma M, Li L, et al.Association between sensitivity to thyroid hormones and dyslipidemia in patients with coronary heart disease[J].Endocrine,2022,79(3):459-468.
[7] 魏留军,高航.替米沙坦联合硝苯地平控释片治疗冠心病伴轻度高血压的效果及对血管内皮功能的影响[J].中国实用医药,2021,16(19):156-158.
[8] Xie H, Li J, Zhu X, et al.Association between healthy lifestyle and the occurrence of cardiometabolic multimorbidity in hypertensive patients: a prospective cohort study of UK Biobank[J].Cardiovasc Diabetol,2022,21(1):199-199.
[9] 田拂晓,武小琴,王晶,等.硝苯地平联合依那普利对老年冠心病伴高血压患者血脂代谢血管内皮功能及炎症反应的影响[J].河北医学,2023,29(5):867-872.
[10] 李惠,宋雨.苯磺酸氨氯地平联合缬沙坦对缓解冠状动脉粥样硬化性心脏病伴高血压的效果分析[J].中国临床医生杂志,2023,51(9):1054-1057.
[11] 张志改. 缬沙坦联合硝苯地平对老年2型糖尿病肾病合并高血压患者血压控制及肾功能的影响[J].医药论坛杂志,2020,41(8):130-133.
[12] 王璐. 缬沙坦联合他汀类药物治疗冠心病的疗效分析[J].中国实用医药,2023,18(24):12-15. |
